BPTH
Price:
$0.04
Market Cap:
$373.69K
Bio-Path Holdings, Inc. is a U.S.-based pharmaceutical company focused on developing RNAi nanoparticle drugs for oncology, with programs spanning both clinical and preclinical stages. Its innovative product development is centered around the DNAbilize platform, a drug delivery and antisense technology that employs a P-ethoxy modified deoxyribonucleic acid (DNA) backbone. This modification is specifically engineered to shield the DNA from premature degradation. The company's lead drug candidate, prexigebersen, is presently in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. Additionally, Bio-Path is advancing Liposomal Bcl-2 for refracto...[Read more]
Industry
Biotechnology
IPO Date
2008-03-04
Stock Exchange
OTC
Ticker
BPTH
According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 76.46%. This represents a change of 270.16% compared to the average of 20.66% of the last 4 quarters.
The mean historical ROE of Bio-Path Holdings, Inc. over the last ten years is -1108.96%. The current 76.46% ROE has changed -106.90% with respect to the historical average. Over the past ten years (40 quarters), BPTH's ROE was at its highest in in the September 2024 quarter at 297.05%. The ROE was at its lowest in in the December 2024 quarter at -1787.66%.
Average
-1108.96%
Median
-84.49%
Minimum
-6424.68%
Maximum
105.51%
Discovering the peaks and valleys of Bio-Path Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.64%
Maximum Annual ROE = 105.51%
Minimum Annual Increase = -101.64%
Minimum Annual ROE = -6424.68%
| Year | ROE | Change |
|---|---|---|
| 2025 | 105.51% | -101.64% |
| 2024 | -6424.68% | 76.22% |
| 2023 | -3645.80% | 3.64% |
| 2022 | -97.61% | 138.08% |
| 2021 | -41.00% | -43.09% |
| 2020 | -72.04% | 78.60% |
| 2019 | -40.33% | -94.28% |
| 2018 | -704.68% | 709.43% |
| 2017 | -87.06% | 6.28% |
| 2016 | -81.92% | 47.12% |
The current ROE of Bio-Path Holdings, Inc. (BPTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3321.66%
5-year avg
-2020.72%
10-year avg
-1108.96%
Bio-Path Holdings, Inc.’s ROE is greater than Orgenesis Inc. (-1683.22%), less than Emmaus Life Sciences, Inc. (13.78%), greater than SQZ Biotechnologies Company (-87.75%), greater than Helix BioMedix, Inc. (-30.45%), less than Indocan Resources Inc. (0%), greater than Paion AG (-8.51%), greater than Elixinol Wellness Limited (-76.30%), less than Yulong Eco-Materials Limited (1.72%), greater than Unity Biotechnology, Inc. (-500.62%), less than Vibe Growth Corporation (39.75%),
| Company | ROE | Market cap |
|---|---|---|
| -1683.22% | $1.65M | |
| 13.78% | $673.81K | |
| -87.75% | $707.79K | |
| -30.45% | $402.23K | |
| 0% | $74.08K | |
| -8.51% | $75.26K | |
| -76.30% | $869.60K | |
| 1.72% | $1.45K | |
| -500.62% | $965.60K | |
| 39.75% | $304.48K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bio-Path Holdings, Inc.'s ROE?
How is the ROE calculated for Bio-Path Holdings, Inc. (BPTH)?
What is the highest ROE for Bio-Path Holdings, Inc. (BPTH)?
What is the 3-year average ROE for Bio-Path Holdings, Inc. (BPTH)?
What is the 5-year average ROE for Bio-Path Holdings, Inc. (BPTH)?
How does the current ROE for Bio-Path Holdings, Inc. (BPTH) compare to its historical average?